Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Hiscox CEO invests; Coca-Cola HBC counsel exercises, sells options

(Sharecast News) - Hiscox was among those on the list of director buys on Friday, after its chief executive officer added to his holding. The FTSE 100 company said Aki Hussain picked up 15,000 shares on 29 August, in a single transaction on the London Stock Exchange.

Hussain paid 1,004p for each share, valuing the transaction at a total of £150,600.

On the selling side of the ledger was Coca-Cola HBC, after its general counsel and company secretary exercised a tranche of share options before selling the shares.

The FTSE 100 drinks bottling giant said Jan Gustavsson exercised 30,000 share options at a strike price of 1,256p apiece, giving that side of the transaction a value of £376,800.

Gustavsson then sold the 30,000 shares on London's market, at a price of 2,310p apiece, giving the sale on 31 August a value of £693,000.

At 1317 BST, shares in Hiscox were up 0.75% at 1,005p, while those in Coca-Cola HBC were 0.66% weaker at 2,263p.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Hiscox Limited (di) (HSX) Director name: Hussain,Hamayou Akbar Amount purchased: 15,000 @ 1,004.00p Value: �150,600.00

Vaalco Energy, Inc (di) (EGY) Director name: Maxwell,George Walter Mitchell Amount purchased: 5,000 @ $4.11 Value: $16,945.25

Vaalco Energy, Inc (di) (EGY) Director name: Fawthrop,Andrew L Amount purchased: 4,000 @ $4.11 Value: $13,549.93

Top Director Sells

Coca-cola Hbc Ag (cdi) (CCH) Director name: Bogdanovic,Zoran Amount sold: 5,528 @ 2,315.00p Value: �127,973.20

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 2,425 @ $3.70 Value: $7,398.78

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 1,501 @ $3.70 Value: $4,579.62

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 393 @ $3.70 Value: $1,200.68

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 393 @ $3.70 Value: $1,200.68

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 309 @ $3.73 Value: $950.42

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 165 @ $3.72 Value: $506.14

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 107 @ $3.71 Value: $327.34

Maxcyte (di) (MXCT) Director name: Johnston ,John Amount sold: 100 @ $3.70 Value: $305.10

Share this article

Related Sharecast Articles

Director dealings: Roadside Real Estate CEO makes share purchase
(Sharecast News) - Roadside Real Estate revealed on Friday that Tarncourt Capital, an entity controlled by chief executive Charles Disckson, had acquired 19.76m ordinary shares in the AIM-listed energy forecourt real estate business.
Director dealings: Sthree CEO raises stake
(Sharecast News) - Sthree revealed on Thursday that chief executive Timo Lehne had acquired 20,427 shares in the London-listed staffing specialist.
Director dealings: Next director makes share purchase
(Sharecast News) - Next revealed on Wednesday that independent non-executive director Jeni Mundy had acquired 160 ordinary shares in the FTSE 100-listed retailer.
Director dealings: IG Group chairman snaps up shares
(Sharecast News) - IG Group revealed on Tuesday that chairman Andrew Barron had acquired 36,416 ordinary shares in the FTSE 100-listed fintech firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.